Promyelocytic Leukemia

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2022-10-26
Clinical Trial Update: Effectiveness and Safety of Therapy Based on Attenuated ATO Plus Low-Dose ATRA in Patients With APL [Phase 1, Phase 2]
A clinical trial evaluating the effectiveness and safety of an attenuated ATO plus low-dose ATRA regimen in patients with promyelocytic leuk…